| 		    	
		 | 
		
		
		
 
		 
		
			  | 
		 
		
			 | 
		 
		
			
 
              
              
    
        
            
                 
                     | 
                 
                 
                           :   ȹ   ۹ 㳶  ȯ | 
                 
                 
                     ָ, ī ij, Ÿ ־  α ǰ ߴ  ۹  70  3 ߴ.   ֱ 㳶     Ȱ   ٰ . 㳶̶  ȯ̰, ǽ    㳶,  ̹ ߰ ư  㳶    ϰ ϴ  㳶    Ѵ. Ư 㳶  ϴ 찡  80% ϰ , Ǽ̳ ؼ  Ÿ Ѵ. ߺ ü    2.7%, 9 شѴ. ʱ 㳶   쵵 , 㼮    Ư  ȣϴ 찡  ߰ ƴ. ׳  ϰ Ÿ  , Ư ʿ  Ź ̴. ̿ܿ  30~60% 㳶 ȯڿ Ȳ  ϱ ϴµ,  㵵  ̾  鼭    Ÿ ̴. ̷ 㳶   ִ  Ȯ ʱ , 㼮  ٸ ȯ ǽϰ ˻糪  ϴٰ  ߰ߵǴ 쵵 ִ  ˷. 㳶 ij CT, MRI, ð ༺ (ERCP), ǰ氣 㵵(PTC)  ˻縦    ִ. ̸  㳶 ܵ , 㳶  īŸ(Capecitabine), Ÿ(Gemcitabine)   Ȱ ȭп 缱 ġ  Ѵ. Ư ϼ 㳶 ̳   ѵ ʱ ܰ迡 㳶ε ġᰡ ϴ.  㳶 ġϴ İ    Ѵ. 2023 ǥ ߾ӾϵϺ ڷῡ ϸ 2017~2021  㳶  Ÿ 㵵 5  28.9%,  30.0%,  27.7% Ȯεƴ. 5  15.9%     ̴. ʱ 1 ߰  5  90% ̻ ,    ܰ ġᰡ ʾ 찡 . ֺ ⳪   ̵ Ŀ ߰ϰų 3~4   Ŀ ڴʰ ߰ϸ鼭   ̴. ߷  ε, ġ  5Ⱓ   ġǴ  5%  ϴ  ˷.㼮  㳶 ߺ 衦ǰ Ĵ ,  ȯ ġᰡ ߿㳶 ü   ִ   , 㳶   ϳ 㼮 Ǵ ŭ, 㼮 ϴ  ϴ     ִ. Ϳ  㼮 ִ     㳶 ߺ  5~10    Ȯεƴ. 㼮 ַ ü ݷ  ġ鼭 µ,     Ľ ¥ ⸧  ȣ     Ȱ  ȴ. ݴ  ̾Ʈ  DZ ϴµ, ص  뷮 ̴ 쿡    ʰ ̸鼭 㼮    ִ.  ߳ Ŀ  ãƿ  ִٰ ˷ 㼮 ֱٿ 20~30  ̿  ãƺ  ִ ȯ ƴ. 㼮  ߱ ؼ    ȭ Ľ ϰ,   ǰ Ĵ   ϴ    ̴. ٸ 㼮 ߰ߵƴٰ ؼ  㳶 ̾  ƴ ŭ ġ ϰų, 㳶    ٷ  ʿ . 㳶 ؾ ϴ  㼮   ȸȭ 㳶, 㳶 ,  շ ̻  ߰ߵ . ̶   ɼ  , ̸  ϴ  ȴ.  ۿ ˾缺 忰  ȭ  ⸸ ƼǪ  ⼱õ    ִ 쿡  㳶,   ջ   ŭ 豺   ִ. ̿  豺 ݵ   ް,  ȯ   ġḦ Ͽ 㳶   ֵ ؾ Ѵ.
    | 
                 
                 
                    
                    | 
                        
                     | 
                 
             
            
         | 
     
 
          
	
			 | 
		 
		
			 | 
		 
		 
		 | 
	 
	 
	
 
	
	 | 
	 |